Introduction
COLLIN Lab & Pilot Solutions GmbH is a German manufacturer of laboratory, pilot, and production-scale plastics processing systems headquartered in Maitenbeth, Bavaria. The company specializes in modular equipment for plastics development, testing, and scale-up, serving customers in polymer production, compounding, film manufacturing, medical technology, pharmaceuticals, and research institutions.
Founded in 1972, COLLIN has built its reputation around extrusion-focused machinery and integrated process lines, with product families such as Teach Line, Lab Line, Pilot Line, Medical Line, and Polytest Line. Its portfolio includes single-screw extruders, calenders, roll mills, platen presses, compounders, mono- and coextrusion lines, pressure filter tests, rheometers, and optical inspection systems, positioning the company in a niche that bridges laboratory development and industrial production.
COLLIN operates within the broader plastics machinery sector and is part of the NGA company group, which also includes related recycling and plastics technology businesses. Public company information indicates an international sales and service footprint, with subsidiaries or representations in the United States, Singapore, India, and other markets, and a strong export orientation.
History and Development
COLLIN was established in 1972 by Dr. Heinrich Collin as Dr. Collin Systementwicklung, and the company’s first patent that year concerned modular calendering systems. This early emphasis on modularity remains central to the company’s equipment philosophy.
A second milestone came with the company’s evolution from a small engineering business into a specialist supplier of lab and pilot lines for plastics processing and research, with later branding under the COLLIN name and an expanding international customer base. By 2022, the company stated that it had more than 135 employees, over 35 representative agencies worldwide, and an export rate of 85%.
A third important development was COLLIN’s integration into the NGA Group, which the company describes as strengthening its long-term position through a broader industrial platform and global service structure. Independent corporate databases also record a 2014 acquisition by Next Generation Recycling Machines, although current company materials emphasize the wider NGA group structure rather than the transaction itself.
Business Operations and Segments
COLLIN’s business is centered on the design and manufacture of modular process engineering systems for plastics research, development, and small-scale production.
Its operating focus can be grouped into several segments:
- Laboratory systems for material characterization, formulation trials, and process development.
- Pilot lines for upscaling from test quantities to production-relevant conditions.
- Specialized medical and pharmaceutical systems for applications such as catheter and IV-bag production.
- Production-related systems for selected customers requiring compact, technically controlled manufacturing lines.
The company’s customer base includes material manufacturers, compounders, film producers, medical and pharmaceutical companies, universities, laboratories, and research institutes. This mix makes COLLIN both an industrial machinery supplier and a technical development partner for process optimization and product validation.
Products and Technologies
COLLIN’s portfolio covers a broad range of plastics processing equipment, with particular strength in extrusion-based systems.
Main product categories
- Extruders for single-screw processing and laboratory-scale compound development.
- Calenders for sheet and film processing.
- Roll mills and platen presses for material preparation and testing.
- Compounders for formulation work and process evaluation.
- Mono- and coextrusion lines for flat film, blown film, tube, pipe, and profile applications.
- Quality-control systems such as pressure filter tests, rheometers, and optical inspection systems.
- Medical tubing and medical production systems for regulated applications.
Technical characteristics
COLLIN emphasizes modular system design, allowing customers to configure equipment for specific test programs or process routes. The company’s systems are used not only for direct material processing but also for material analysis, process simulation, and scale-up studies, which are essential in polymer development and product qualification.
Its equipment range supports a progression from basic formulation trials to pilot testing and production transfer, which is particularly important in industries where process repeatability, dimensional accuracy, and material properties must be validated before full-scale investment.
Applications and End Markets
COLLIN’s systems are used across multiple plastics-intensive sectors:
- Polymer producers and processors, for formulation, compounding, and process optimization.
- Film and packaging manufacturers, including flat and blown film development.
- Medical technology, especially tubing and fluid-handling products.
- Pharmaceutical manufacturing, where controlled extrusion and hygienic process design are important.
- Research institutions and universities, for material science and process engineering work.
- Industrial and advanced materials sectors, including applications mentioned by the company in automotive, aviation, and battery-related development.
This application profile reflects the company’s position in the value chain: COLLIN does not primarily sell commodity machinery, but rather specialized process technology that supports experimentation, validation, and pre-production manufacturing.
Global Presence and Market Position
COLLIN describes itself as a premium supplier with international reach and a high export ratio. Company location information lists headquarters in Germany and sales/service entities or affiliated operations in the United States and Singapore, with additional references to activity in India and broader global representative coverage.
The company’s market position is best understood as that of a specialist niche manufacturer within plastics machinery rather than a mass-market equipment producer. Chinaplas-related exhibitor material identifies the company as a niche participant in the international plastics exhibition ecosystem, consistent with its focus on advanced processing and laboratory systems.
Sustainability and Environmental Initiatives
Publicly available company materials in the provided sources do not set out a detailed sustainability report or quantified emissions targets. However, COLLIN’s core business model can contribute indirectly to more efficient plastics development by enabling process optimization, material testing, and scale-up with reduced trial waste.
Its relationship to the broader NGA group also places it within an industrial structure that includes recycling-related technology businesses, although the supplied sources do not describe a direct operational integration between COLLIN’s products and recycling systems. Based on the available evidence, any sustainability characterization should be limited to the company’s role in development efficiency, testing precision, and controlled process engineering.
Leadership and Corporate Structure
The company is described as owner-managed in its own materials. Third-party company listings identify Dr. Friedrich Kastner as CEO or management contact, while current shareholding information in COLLIN’s history page states that, as of May 2026, Dr. Kastner GmbH holds 70% of NGA GmbH, Verstraten GmbH 20%, and Corné Verstraten 10% personally.
COLLIN is formally organized in Germany as a limited liability company, with corporate registry records in Traunstein and a business address in Gewerbestrasse 11, 83558 Maitenbeth.
Innovations and Future Outlook
COLLIN’s long-term competitive strength lies in its combination of modular engineering, process know-how, and customized pilot-scale systems. That capability is relevant to current industry trends, including:
- higher demand for medical-grade plastics processing,
- increased need for rapid material development and validation,
- growing interest in multi-layer film structures and advanced packaging,
- and the move toward more efficient scale-up from laboratory to production.
The company’s future development is likely to continue along these lines, with emphasis on technical specialization rather than volume manufacturing. Its core value proposition remains the ability to help customers reduce uncertainty in plastics process development and translate laboratory results into production-ready systems.
Summary
COLLIN Lab & Pilot Solutions GmbH is a German specialist in modular plastics laboratory and pilot equipment, with a history dating to 1972 and a strong focus on extrusion, testing, and process scale-up. Its relevance in the plastics industry stems from its role in bridging R&D, technical validation, and production implementation for customers in polymers, packaging, medical technology, pharmaceuticals, and research.
References
- •
CPS+ eMarketplace. (n.d.). COLLIN LAB & PILOT SOLUTIONS GMBHCOLLIN LAB & PILOT SOLUTIONS GMBH. CPS+ eMarketplace. https://www.chinaplasonline.com/eMarketplace/ExhibitorInfo?CompId=1005615Link